Compounds > cephalosporin c
Page last updated: 2024-08-24

cephalosporin c and daptomycin

cephalosporin c has been researched along with daptomycin in 110 studies

Research

Studies (110)

TimeframeStudies, this research(%)All Research%
pre-19901 (0.91)18.7374
1990's3 (2.73)18.2507
2000's12 (10.91)29.6817
2010's74 (67.27)24.3611
2020's20 (18.18)2.80

Authors

AuthorsStudies
Hanberger, H1
Adinolfi, LE; Marrone, A; Ruggiero, G; Tripodi, MF; Utili, R1
Bemis, AT; Norton, JA; Reynolds, J; Smith, JW; Treger, T; Wheat, LJ1
Garcia, R; Raad, I1
Barrett, JF; Bronson, JJ1
Hermsen, ED; Hotchkiss, JR; Hovde, LB; Rotschafer, JC1
Georgopapadakou, N1
de Roux, A; Lode, H; Schmidt-Ioanas, M1
De Mendonça, R; De Ryck, R; Denis, O; Deplano, A; Hallin, M; Nonhoff, C; Struelens, MJ; Vanhoof, R1
Khardori, N1
Loffler, CA; Macdougall, C1
Aksoy, DY; Unal, S1
Cheung, CM; Leonard, SN; Rybak, MJ1
Decker, CF; Johnson, MD1
Steiner, I; Wagner, CC; Zeitlinger, M1
Corey, GR; Stryjewski, ME1
Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P1
Cattoir, V; Daurel, C1
Appelbaum, PC; Ednie, LM; Lin, G1
Leonard, SN; Rybak, MJ; Vidaillac, C1
Johnson, L; Pawlak, J; Saravolatz, L1
Arhin, FF; Beaulieu, S; Belley, A; McKay, G; Moeck, G; Parr, TR; Sarmiento, I1
Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C1
Husain, N; Johnson, LB; Pawlak, J; Saravolatz, LD1
Rybak, MJ; Steed, ME; Vidaillac, C1
Amador, G; Batard, E; Biek, D; Caillon, J; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G1
Rybak, MJ; Steed, M; Vidaillac, C1
Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS1
Abbanat, D; Amsler, K; Barron, AM; Fernandez, J; Flamm, RK; Hastings, J; He, W; Lynch, AS; Melton, JL; Queenan, AM; Shang, W1
Citron, DM; Goldstein, EJ; Tyrrell, KL; Warren, YA1
Graviss, EA; Marconescu, P; Musher, DM1
Andes, D; Berti, AD; Hutson, PR; Rose, WE; Schulz, LT; Shukla, SK; Striker, R1
Pogliano, J; Rose, WE; Rybak, MJ; Sakoulas, G; Tewhey, R; Werth, BJ1
Bheemreddy, S; Biedron, C; Chalana, IK; Collins, V; Hayakawa, K; Ho, K; Judge, T; Kamatam, S; Kaye, KS; Khammam, V; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Parveen, S; Pogue, JM; Reddy, SM; Rybak, MJ; Tiwari, N; Tumma, RS; Yousuf, A1
Das, D; Garcia, LG; Lemaire, S; Mélard, A; Rozenberg, R; Tulkens, PM; Van Bambeke, F1
Andes, DR; Craig, WA; Lee, DG; Murakami, Y1
Heidari, A; Jongsma, K; Joson, J1
Richards, EP; Sharff, KA; Townes, JM1
Flamm, RK; Jones, RN; Sader, HS1
Crum-Cianflone, N; Haddad, F; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G1
Bhalodi, AA; Hagihara, M; Kuti, JL; Nicolau, DP1
Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG1
Humphries, R; Nizet, V; Nonejuie, P; Olson, J; Pogliano, J; Rose, W; Sakoulas, G1
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS1
Muscedere, J1
Johnson, LB; Martin, H; Pawlak, J; Saravolatz, LD; Saravolatz, SN1
Barber, KE; Ireland, CE; Rybak, MJ; Werth, BJ1
Ariza, J; Cabellos, C; Force, E; Garrigós, C; Platteel, AC; Tubau, F; Vivas, M1
Arias, CA; Carvajal, LP; Díaz, L; Munita, JM; Panesso, D; Reyes, J; Rincón, S1
Barber, KE; Ireland, CE; Nonejuie, P; Pogliano, J; Rybak, MJ; Sakoulas, G; Stone, NE; Werth, BJ1
Bressler, AM; Casapao, AM; Dhand, A; Ebright, JR; Goff, DA; Johns, S; Kaatz, GW; Kullar, R; Lee, Y; Moise, PA; Nizet, V; Nonejuie, P; Okumura, CY; Olson, J; Pogliano, J; Rose, WE; Rybak, MJ; Sakoulas, G1
Barber, KE; Rybak, MJ; Sakoulas, G1
Barber, KE; Rybak, MJ; Werth, BJ1
Barber, KE; Nonejuie, P; Pogliano, J; Rybak, MJ; Sakoulas, G; Tran, KN; Werth, BJ1
Barber, KE; Raut, A; Rybak, MJ; Smith, JR1
Baxi, SM; Chan, D; Jain, V1
Gomes, DM; LaPlante, KL; Ward, KE1
Barber, KE; Boles, BR; Ireland, CE; Rose, WE; Rybak, MJ; Smith, JR1
Cunha, BA; Gran, A1
Baos, E; Candel, FJ; Nieto, M; Picazo, JJ1
Bouquié, R; Boutoille, D; Caillon, J; Dailly, E; Deslandes, G; Grégoire, M; Jolliet, P; Leroy, AG; Malandain, D; Renaud, C1
Esterbrooks, DJ; Haddad, TM; Sundaragiri, PR; Vallabhajosyula, S1
Atwood, DN; Beenken, KE; Lantz, TL; Lynn, WB; Meeker, DG; Mills, WB; Smeltzer, MS; Spencer, HJ1
Raut, A; Rybak, MJ; Smith, JR; Yim, J1
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F1
Arya, A; Barber, KE; Hallesy, J; Rybak, MJ; Singh, NB; Smith, JR; Yim, J1
Basuino, L; Chambers, HF; Choo, EJ; Hamilton, SM; Moise, P1
Deresinski, S; Holubar, M; Meng, L1
Castiglioni, A; Castiglioni, B; La Canna, G; Oltolini, C; Ossi, C; Pajoro, U; Scarpellini, P; Tassan Din, C1
Candel, FJ; Chiarella, F; García, AB; López, L; Viñuela-Prieto, JM1
Casapao, AM; Claeys, KC; Davis, SL; Klinker, KP; Lagnf, AM; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ1
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R1
Arshad, S; Hartman, P; Huang, V; Moreno, D; Perri, MB; Zervos, MJ1
Arias, CA; Carvajal, LP; Chambers, HF; Diaz, L; Garavito, JD; Miller, WR; Munita, JM; Nigo, M; Panesso, D; Rios, R; Tran, TT; Wanger, A; Weinstock, G1
Boka, K; Cortes, J; Lee, Y; Sagar, AS; Sandhu, U1
Ashbaugh, AG; Jain, SK; Miller, LS; Miller, RJ; Ordonez, AA; Ortines, RV; Saini, V; Sterling, RS; Thompson, JM; Wang, Y1
Arias, CA; Bayer, AS; Garcia de la Maria, C; Miró, JM; Mishra, NN; Rice, S; Rybak, MJ; Singh, NB; Smith, JR; Stamper, K; Sullam, P; Tran, TT; Yim, J1
Abad, L; Benito, Y; Bes, M; Camus, C; Chidiac, C; Dupieux, C; Ferry, T; Laurent, F; Lustig, S; Trouillet-Assant, S; Valour, F1
Chan, D; Chang, E; Saedi-Kwon, H; Schwartz, J; Turner, RB; Wilson, DE; Won, R1
Cortes-Penfield, N; Hunter, A; Oliver, NT; Rodriguez-Barradas, M1
Alvarez, DN; Bayer, AS; Farah, S; Garcia-de-la-Maria, C; Miro, JM; Mishra, NN; Sakoulas, G; Zapata, B1
Andreoni, F; Eberl, L; François, P; Kalawong, R; Mairpady Shambat, S; Menzi, C; Toyofuku, M; Zinkernagel, AS1
Cuénod, A; Egli, A; Hinic, V; Khanna, N; Kuehl, R; Morgenstern, M; Wüthrich, D1
Jamal, M; Nesher, L; Prince, RA; Raad, I; Rice, SA; Rolston, KVI; Rybak, MJ1
Gil Romero, Y; Gómez-Garcés, JL1
Bongiorno, D; Campanile, F; Mongelli, G; Stefani, S1
Croxatto, A; Duss, FR; Garcia de la Mària, C; Giulieri, S; Lamoth, F; Manuel, O; Miró, JM1
Attanasio, V; Bernardo, M; Carozza, A; Francisci, D; Oltolini, C; Pallotto, C; Palmiero, G; Ripa, M; Scarpellini, P; Tascini, C1
Morata, L; Soriano, A1
Chambers, HF; Deresinski, S; Holubar, M; Kalil, AC1
Geriak, M; Haddad, F; Kullar, R; LaPlante, K; Nizet, V; Rose, W; Sakoulas, G; Zervos, M1
Drusano, G; Kaye, KS; Patel, T1
Engelhardt, M; Fowler, VG; Hamed, K; Holland, TL; Jones, ME; Saulay, M; Seifert, H1
Gomart, C; Hulin, A; Martin, M; Mounier, R; Roujansky, A1
Brown, SM; Ferraro, J; Goodman, B; Jones, PB; Lopansri, B; Stenehjem, E; Subramanian, A; Webb, BJ1
Cuba, GT; da Costa, TM; Dos Santos, KRN; Kiffer, CRV; Morgado, PGM; Nicolau, DP; Nouér, SA1
Alzueta, N; Castresana, M; Echeverria, A; Gascón, A; Marin, M; Pío, M1
Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT1
Alosaimy, S; Lagnf, AM; Morrisette, T; Rybak, MJ1
Herc, ES; Hutton, MA; Perri, MB; Sundaram, A; Zervos, MJ1
Alegria, W; Deresinski, S; Holubar, M; Meng, L1
Algorri, M; Wong-Beringer, A1
Huang, M; Johnson, TM; Kiser, TH; Miller, MA; Molina, KC; Mueller, SW1
Hung, WC; Lin, SY; Lo, SH; Lu, PL; Tseng, YT1
Abate, G; Frisby, J; Wang, G1
Antonucci, M; Artioli, S; Boni, S; D'Avolio, A; Di Perri, G; Manca, A; Martinelli, L; Nicolò, A; Pacini, G1
Chang, SC; Chen, YC; Chuang, YC; Sheng, WH; Tsai, CE; Wang, JT; Yang, CJ1
Mykietuk, A; Nannini, EC; Obed, MN; Toresani, I1
Belley, A; Eberl, S; Huband, MD; Huynh, HK; Knechtle, P; Nussbaumer-Pröll, A; Zeitlinger, M1
Annaert, P; Martins, FS; Martins, JES; Severino, P; Sy, SKB1

Reviews

17 review(s) available for cephalosporin c and daptomycin

ArticleYear
Quinolone, everninomycin, glycylcycline, carbapenem, lipopeptide and cephem antibacterials in clinical development.
    Current medicinal chemistry, 2001, Volume: 8, Issue:14

    Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Clinical Trials as Topic; Daptomycin; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Minocycline; Prodrugs; Tetracyclines; Tigecycline

2001
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
    Current opinion in critical care, 2005, Volume: 11, Issue:5

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Critical Illness; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin

2005
Antibiotics--past, present, and future.
    The Medical clinics of North America, 2006, Volume: 90, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriophages; beta-Lactams; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Drug Therapy; Fluoroquinolones; Glycopeptides; Humans; Macrolides; Oxazolidinones; Streptogramins; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination

2006
New antimicrobial agents for the treatment of Gram-positive bacterial infections.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:5

    Topics: Acetamides; Anti-Infective Agents; Cephalosporins; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin

2008
Antimicrobial agents in treatment of MRSA infections.
    Disease-a-month : DM, 2008, Volume: 54, Issue:12

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin

2008
New treatments for methicillin-resistant Staphylococcus aureus.
    Current opinion in critical care, 2009, Volume: 15, Issue:5

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Daptomycin; Evidence-Based Medicine; Glycopeptides; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pyrimidines; Streptococcal Infections; Tigecycline

2009
[Update on antimicrobial chemotherapy].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:3

    Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline

2010
Clinical management of septic arthritis.
    Current rheumatology reports, 2013, Volume: 15, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Arthritis, Infectious; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Immunologic Factors; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Risk Factors; Staphylococcal Infections; Treatment Outcome; Virginiamycin

2013
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].
    Biomedica : revista del Instituto Nacional de Salud, 2014, Volume: 34 Suppl 1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Genes, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Staphylococcal Infections; Tigecycline; Vancomycin

2014
Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.
    Infection, 2015, Volume: 43, Issue:6

    Topics: Aged, 80 and over; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome

2015
Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Pharmacotherapy, 2015, Volume: 35, Issue:4

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Linezolid; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2015
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
    Internal and emergency medicine, 2016, Volume: 11, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin

2016
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
    Infectious disease clinics of North America, 2016, Volume: 30, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2016
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
    BMC infectious diseases, 2017, 01-07, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2017
Ceftobripole: Experience in staphylococcal bacteremia.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32 Suppl 3

    Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus

2019
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Infectious disease clinics of North America, 2020, Volume: 34, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2020
Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance.
    The Annals of pharmacotherapy, 2022, Volume: 56, Issue:12

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Resistance; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2022

Trials

1 trial(s) available for cephalosporin c and daptomycin

ArticleYear
Ceftobiprole versus daptomycin in
    Future microbiology, 2020, Volume: 15

    Topics: Adult; Bacteremia; Cephalosporins; Clinical Trials as Topic; Daptomycin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure; Treatment Outcome; Young Adult

2020

Other Studies

92 other study(ies) available for cephalosporin c and daptomycin

ArticleYear
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
    Scandinavian journal of infectious diseases. Supplementum, 1992, Volume: 81

    Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin

1992
Influence of subinhibitory concentrations of loracarbef (LY 163892) and daptomycin (LY 146032) on bacterial phagocytosis, killing and serum sensitivity.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:4

    Topics: Bacteria; Blood Bactericidal Activity; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Humans; Immune Sera; Macrophages; Neutrophils; Peptides; Phagocytosis

1990
Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Methicillin; Penicillin Resistance; Peptides; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

1988
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin

1996
Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12

    Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Colony Count, Microbial; Daptomycin; Dialysis Solutions; Hydrogen-Ion Concentration; Methicillin Resistance; Peritoneal Dialysis; Peritonitis; Protein Binding; Staphylococcus; Streptococcus; Vancomycin

2003
Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference.
    Expert opinion on emerging drugs, 2004, Volume: 9, Issue:1

    Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Clinical Trials as Topic; Daptomycin; Drug Design; Drug Evaluation, Preclinical; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Marketing; Mice; Protein Synthesis Inhibitors; Ribosomes; Structure-Activity Relationship; Topoisomerase II Inhibitors

2004
In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:8

    Topics: Anti-Bacterial Agents; Belgium; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Exotoxins; Genes, Bacterial; Hospitals; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Staphylococcal Infections; Staphylococcus aureus; Tigecycline

2006
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:6

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin

2007
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2008
Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption.
    International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:3

    Topics: Adsorption; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Dose-Response Relationship, Drug; Hemofiltration; Humans; In Vitro Techniques; Membranes, Artificial; Metabolic Clearance Rate; Models, Biological; Rheology

2009
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin

2010
Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sisomicin; Time Factors

2010
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:6

    Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin

2010
In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2010
Assessment of oritavancin serum protein binding across species.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Cefpirome; Cephalosporins; Daptomycin; Dogs; Glycopeptides; Humans; Lipoglycopeptides; Mice; Microbial Sensitivity Tests; Protein Binding; Rats; Species Specificity; Staphylococcus aureus

2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin

2010
In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cephalosporins; Daptomycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus

2010
Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acetamides; Anti-Infective Agents; Cefepime; Cephalosporins; Daptomycin; Drug Combinations; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Trimethoprim, Sulfamethoxazole Drug Combination

2010
Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Female; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Minocycline; Rabbits; Rodent Diseases; Staphylococcal Infections; Tigecycline; Treatment Outcome

2011
Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests

2011
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin

2011
Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Dosage Calculations; Drug Synergism; Endocarditis, Bacterial; Female; Humans; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2012
In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cephalosporins; Colony Count, Microbial; Corynebacterium; Culture Media; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Vancomycin

2012
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:8

    Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus

2012
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Aminoacyltransferases; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Ceftaroline; Cell Membrane; Cell Wall; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Drug Synergism; Fluorescent Dyes; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Models, Biological; Mutation; Vancomycin; Vancomycin Resistance

2013
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
    Infection control and hospital epidemiology, 2012, Volume: 33, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Comorbidity; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Vancomycin; Vancomycin Resistance

2012
Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monocytes; Oxazolidinones; Vancomycin

2013
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin

2013
Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Debridement; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2013
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2013
Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Ceftaroline; Cell Membrane; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged

2013
In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Statistical; Vancomycin; Vancomycin Resistance

2014
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
    Clinical and experimental pharmacology & physiology, 2014, Volume: 41, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin

2014
Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Anti-Bacterial Agents; Ceftaroline; Cell Wall; Cephalosporins; Daptomycin; Drug Synergism; Enterococcus faecium; In Vitro Techniques; Membrane Fluidity; Microbial Sensitivity Tests; Vancomycin Resistance

2014
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin

2014
Which antibiotic for hospital acquired pneumonia caused by MRSA?
    BMJ (Clinical research ed.), 2014, Feb-13, Volume: 348

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin

2014
Ceftaroline-heteroresistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2014
Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Computer Simulation; Daptomycin; Drug Combinations; Endocarditis, Bacterial; Half-Life; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2014
Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11

    Topics: Animals; Cephalosporin Resistance; Cephalosporins; Daptomycin; Female; Meningitis, Pneumococcal; Rabbits; Treatment Outcome

2014
Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11

    Topics: Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Phenotype; Staphylococcus aureus

2014
Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
    Clinical therapeutics, 2014, Oct-01, Volume: 36, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Cathelicidins; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Female; Humans; Male; Mice; Middle Aged; Salvage Therapy; Staphylococcal Infections; Staphylococcus

2014
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin

2015
The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:2

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation

2015
Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:2

    Topics: Ampicillin; Cephalosporins; Daptomycin; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Humans; Microbial Sensitivity Tests; Vancomycin Resistance

2015
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:5

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci

2015
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Anti-Bacterial Agents; Biofilms; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Half-Life; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin

2015
Successful treatment of meticillin-resistant Staphylococcus aureus (MRSA) aortic prosthetic valve endocarditis with prolonged high-dose daptomycin plus ceftaroline therapy.
    International journal of antimicrobial agents, 2015, Volume: 46, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Bicuspid Aortic Valve Disease; Ceftaroline; Cephalosporins; Daptomycin; Endocarditis; Heart Defects, Congenital; Heart Valve Diseases; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Treatment Outcome

2015
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin

2015
Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography-tandem mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2016, Jan-25, Volume: 118

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Humans; Linezolid; Rifampin; Solid Phase Extraction; Tandem Mass Spectrometry

2016
Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon.
    BMJ case reports, 2015, Nov-03, Volume: 2015

    Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Fatal Outcome; Heart Valve Diseases; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Staphylococcal Infections; Tricuspid Valve; Vancomycin

2015
Regulatory Mutations Impacting Antibiotic Susceptibility in an Established Staphylococcus aureus Biofilm.
    Antimicrobial agents and chemotherapy, 2016, Jan-11, Volume: 60, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Catheter-Related Infections; Catheters; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Humans; Mice; Microbial Sensitivity Tests; Sigma Factor; Staphylococcal Infections; Staphylococcus aureus

2016
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci

2016
Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillanic Acid; Staphylococcus aureus; Tazobactam

2016
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Animals; beta-Lactams; Ceftriaxone; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Ertapenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits

2016
Meticillin-resistant Staphylococcus aureus endocarditis: first report of daptomycin plus ceftobiprole combination as salvage therapy.
    International journal of antimicrobial agents, 2016, Volume: 47, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Endocarditis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Salvage Therapy; Staphylococcal Infections; Treatment Outcome

2016
In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus.
    Journal of medical microbiology, 2016, Volume: 65, Issue:10

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2016
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2

    Topics: Aged; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Endocarditis; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin

2017
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 57

    Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Female; Hospitalization; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Michigan; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin

2017
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gene Expression; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin

2017
Antimicrobial salvage therapy for native valve MRSA endocarditis.
    The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Vancomycin

2017
Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model.
    The Journal of bone and joint surgery. American volume, 2017, Apr-19, Volume: 99, Issue:8

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Doxycycline; Drug Combinations; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Treatment Outcome

2017
Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
    The Journal of antimicrobial chemotherapy, 2017, 08-01, Volume: 72, Issue:8

    Topics: Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Therapy, Combination; Endocarditis; Gentamicins; Humans; Models, Biological; Streptococcal Infections; Streptococcus mitis; Treatment Outcome

2017
Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA.
    The Journal of antimicrobial chemotherapy, 2017, Dec-01, Volume: 72, Issue:12

    Topics: Anti-Bacterial Agents; Ceftaroline; Cell Line; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Synergism; Humans; Methicillin Resistance; Microbial Viability; Osteoblasts; Oxacillin; Staphylococcus aureus

2017
Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline.
    The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Female; Humans; Incidence; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Retrospective Studies; Staphylococcal Infections; Vancomycin

2018
Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:8

    Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Salvage Therapy; Staphylococcal Infections

2018
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
    Current microbiology, 2018, Volume: 75, Issue:8

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Combinations; Drug Resistance, Bacterial; Gentamicins; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Rifampin; Streptococcus mitis; Streptococcus oralis; Trimethoprim, Sulfamethoxazole Drug Combination

2018
Antibiotics Stimulate Formation of Vesicles in
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2

    Topics: Anti-Bacterial Agents; Bacteriophages; Ceftaroline; Cephalosporins; Cytoplasmic Vesicles; Daptomycin; DNA, Bacterial; Floxacillin; Humans; Lysogeny; Peptidoglycan; Staphylococcus aureus

2019
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline.
    The Journal of antimicrobial chemotherapy, 2019, 05-01, Volume: 74, Issue:5

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Genomics; Humans; Inpatients; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Staphylococcal Infections; Vancomycin

2019
Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients.
    Journal of global antimicrobial resistance, 2019, Volume: 17

    Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin

2019
In vitro activity of ceftaroline in combination with other antimicrobials active against Staphylococcus spp.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2020, Volume: 38, Issue:1

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin

2020
Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance.
    Diagnostic microbiology and infectious disease, 2019, Volume: 95, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Genotype; Humans; Italy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Staphylococcal Infections

2019
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    The Journal of antimicrobial chemotherapy, 2019, 09-01, Volume: 74, Issue:9

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Synergism; Endocarditis; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections

2019
Ceftobiprole for the treatment of infective endocarditis: A case series.
    Journal of global antimicrobial resistance, 2020, Volume: 20

    Topics: Adult; Aged; Aged, 80 and over; Cephalosporins; Daptomycin; Drug Therapy, Combination; Endocarditis; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome

2020
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11

    Topics: Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Standard of Care; Staphylococcal Infections; Staphylococcus aureus

2019
Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11

    Topics: Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Standard of Care; Staphylococcal Infections; Staphylococcus aureus

2019
Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11

    Topics: Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Standard of Care

2019
Multidrug-Resistant Staphylococcus epidermidis Ventriculostomy-Related Infection Successfully Treated by Intravenous Ceftaroline after Failure of Daptomycin Treatment.
    World neurosurgery, 2020, Volume: 136

    Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Female; Humans; Retreatment; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Ventriculostomy

2020
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4

    Topics: Adaptation, Physiological; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Clindamycin; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Retrospective Studies

2020
Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
    BMC infectious diseases, 2020, Jan-23, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Brazil; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2020
Combination of ceftaroline and daptomycin as treatment for complicated osteomyelitis.
    European journal of hospital pharmacy : science and practice, 2021, Volume: 28, Issue:5

    Topics: Ceftaroline; Cephalosporins; Daptomycin; Drug Combinations; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis

2021
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
    The Journal of infectious diseases, 2020, 10-01, Volume: 222, Issue:9

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome

2020
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Cohort Studies; Daptomycin; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome

2020
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus.
    Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:3

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2020
Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus.
    Annals of clinical microbiology and antimicrobials, 2020, Nov-03, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; CD11b Antigen; Ceftaroline; Cephalosporins; Daptomycin; Humans; L-Selectin; Lipopolysaccharides; Neutrophils; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Vancomycin

2020
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Salvage Therapy; Standard of Care; Staphylococcal Infections; Treatment Outcome; Vancomycin

2021
Successful treatment with daptomycin and ceftaroline of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) endocarditis: a case report.
    Journal of global antimicrobial resistance, 2021, Volume: 27

    Topics: Ceftaroline; Cephalosporins; Daptomycin; Endocarditis; Humans; Staphylococcus aureus; Vancomycin-Resistant Staphylococcus aureus

2021
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis.
    Journal of chemotherapy (Florence, Italy), 2022, Volume: 34, Issue:6

    Topics: Anti-Bacterial Agents; Cephalosporins; Daptomycin; Endocarditis; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcal Infections

2022
Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2022
Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia.
    Medicina, 2022, Volume: 82, Issue:5

    Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Retrospective Studies; Salvage Therapy; Staphylococcal Infections; Staphylococcus aureus

2022
Impact of surfactants and other body fluids on in vitro activity of a novel β-lactamase inhibitor enmetazobactam in combination with cefepime against clinical isolates of Klebsiella pneumoniae.
    The Journal of antibiotics, 2023, Volume: 76, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Body Fluids; Cefepime; Cephalosporins; Daptomycin; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Staphylococcus aureus; Surface-Active Agents

2023
Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:9

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Child; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus

2023